Promotion of neuroinflammation in select hippocampal regions in a mouse model of perimenopausal Alzheimer’s disease
Open Access
- 14 May 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 12, 1597130
Abstract
Introduction: Alzheimer’s disease, the most common form of dementia, is characterized by age-dependent amyloid beta (Ab) aggregation and accumulation, neuroinflammation, and cognitive deficits. Significantly, there are prominent sex differences in the risk, onset, progression, and severity of AD, as well as response to therapies, with disease burden disproportionately affecting women. Although menopause onset (i.e., perimenopause) may be a critical transition stage for AD susceptibility in women, the role of early ovarian decline in initial disease pathology, particularly key neuroinflammatory processes, is not well understood.Methods: To study this, we developed a unique mouse model of perimenopausal AD by combining an accelerated ovarian failure (AOF) model of menopause induced by 4-vinylcyclohexene diepoxide (VCD) with the 5xFAD transgenic AD mouse model. To target early stages of disease progression, 5xFAD females were studied at a young age (∼4 months) and at the beginning stage of ovarian failure analogous to human perimenopause (termed “peri-AOF”), and compared to age-matched males. Assessment of neuropathology was performed by immunohistochemical labeling of Ab as well as markers of astrocyte and microglia activity in the hippocampus, a brain region involved in learning and memory that is deleteriously impacted during AD.Results: Our results show that genotype, AOF, and sex contributed to AD-like pathology. Aggregation of Ab was heightened in female 5xFAD mice and further increased at peri-AOF, with hippocampal subregion specificity. Further, select increases in glial activation also paralleled Ab pathology in distinct hippocampal subregions. However, cognitive function was not affected by peri-AOF.Discussion: These findings align with the hypothesis that perimenopause constitutes a period of susceptibility for AD pathogenesis in women.Keywords
This publication has 119 references indexed in Scilit:
- Interactions between menopause and high‐fat diet on cognition and pathology in a mouse model of Alzheimer's diseaseAlzheimer's & Dementia, 2025
- Optoα1AR activation in astrocytes modulates basal hippocampal synaptic excitation and inhibition in a stimulation‐specific mannerHippocampus, 2023
- 2023 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2023
- DREADD‐inactivation of dorsal CA1 pyramidal neurons in mice impairs retrieval of object and spatial memoriesHippocampus, 2022
- Diagnosis and Management of Dementia: ReviewJAMA, 2019
- Sex‐biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi‐omic analysisJournal of Comparative Neurology, 2018
- Cellular and subcellular localization of estrogen and progestin receptor immunoreactivities in the mouse hippocampusJournal of Comparative Neurology, 2010
- Localization of estrogen receptor ?-immunoreactivity in astrocytes of the adult rat brainGlia, 1999
- Functional interconnections between CA3 and the dentate gyrus revealed by current source density analysisHippocampus, 1998
- Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female ratsJournal of Comparative Neurology, 1997